| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,394 |
11,307 |
$653K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,000 |
3,622 |
$289K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,479 |
2,249 |
$163K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,047 |
3,694 |
$117K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,344 |
2,089 |
$49K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,361 |
2,158 |
$25K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
172 |
162 |
$18K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
172 |
161 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
304 |
236 |
$8K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
403 |
332 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
545 |
448 |
$6K |
| 87807 |
|
34 |
29 |
$279.02 |
| 81003 |
|
57 |
53 |
$99.88 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
20 |
18 |
$27.05 |
| 99072 |
|
548 |
491 |
$0.00 |